TETRAULT LYNN A.
SEC Form 4 insider trading activity
TETRAULT LYNN A. has filed 6 SEC Form 4 filings (7 transaction rows) across 3 companies, including ALMS, RYTM, NEO, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.
On the most recent filing, TETRAULT LYNN A. is listed as Director at RHYTHM PHARMACEUTICALS, INC. Inside the rolling window, TETRAULT LYNN A. reported no open-market purchases and 3 open-market sales totaling $3.8M in RYTM and NEO. The largest disclosed transaction in the window is a sale of 37,000 RYTM shares on Jun 22, 2026, worth $3.7M.
Companies traded
Other insiders at ALMS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.8M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has TETRAULT LYNN A. made?
TETRAULT LYNN A. has filed 6 SEC Form 4 filings (7 transaction rows) across 3 companies, including ALMS, RYTM, NEO since 2026.
Which companies does TETRAULT LYNN A. trade?
TETRAULT LYNN A. has filed SEC Form 4 disclosures for 3 companies, including ALMS, RYTM, NEO.
When was TETRAULT LYNN A.'s most recent SEC Form 4 filing?
TETRAULT LYNN A.'s most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.
What is TETRAULT LYNN A.'s total buy and sell value in the current window?
Inside the rolling retention window, TETRAULT LYNN A. bought $0 and sold $3.8M based on SEC Form 4 filings.
What was TETRAULT LYNN A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 37,000 RYTM shares on 2026-06-22, worth $3.7M, per SEC Form 4 filings.